DCC-3009

· Deciphera Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCC-3009, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) [Phase 1, Phase 2]